Friday, February 10, 2017

Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 4

If you are unable to see the message below, click here to view.
Neuropsychopharmacology

TABLE OF CONTENTS

Volume 42, Issue 4 (March 2017)

In this issue
Commentary
Review
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Commentary

Top

Context-Dependent Effects of Inflammation: Reduced Reward Responding is Not an Invariant Outcome of Sickness

Michael R Irwin and Naomi I Eisenberger

Neuropsychopharmacology 2017 42: 785-786; advance online publication, October 25, 2016; 10.1038/npp.2016.245

Full Text

Review

Top

Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders

Rafael T de Sousa, Alexandre A Loch, André F Carvalho, André R Brunoni, Marie Reine Haddad, Ioline D Henter, Carlos A Zarate and Rodrigo Machado-Vieira

Neuropsychopharmacology 2017 42: 787-800; advance online publication, August 11, 2016; 10.1038/npp.2016.149

Abstract | Full Text

Original Articles

Top

Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial

Julie Lasselin, Michael T Treadway, Tamara E Lacourt, Anne Soop, Mats J Olsson, Bianka Karshikoff, Sofie Paues-Göranson, John Axelsson, Robert Dantzer and Mats Lekander

Neuropsychopharmacology 2017 42: 801-810; advance online publication, September 13, 2016; 10.1038/npp.2016.191

Abstract | Full Text

Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation

Jianjun Gao, Lea K Davis, Amy B Hart, Sandra Sanchez-Roige, Lide Han, John T Cacioppo and Abraham A Palmer

Neuropsychopharmacology 2017 42: 811-821; advance online publication, September 15, 2016; 10.1038/npp.2016.197

Abstract | Full Text

How the Brain Wants What the Body Needs: The Neural Basis of Positive Alliesthesia

Jason A Avery, Kaiping Burrows, Kara L Kerr, Jerzy Bodurka, Sahib S Khalsa, Martin P Paulus and W Kyle Simmons

Neuropsychopharmacology 2017 42: 822-830; advance online publication, July 18, 2016; 10.1038/npp.2016.128

Abstract | Full Text

Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder

Erin Walsh, Hannah Carl, Tory Eisenlohr-Moul, Jared Minkel, Andrew Crowther, Tyler Moore, Devin Gibbs, Chris Petty, Josh Bizzell, Moria J Smoski and Gabriel S Dichter

Neuropsychopharmacology 2017 42: 831-843; advance online publication, September 2, 2016; 10.1038/npp.2016.179

Abstract | Full Text

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study OPEN

Gerard Sanacora, Michael R Johnson, Arif Khan, Sarah D Atkinson, Robert R Riesenberg, Juan P Schronen, Michael A Burke, John M Zajecka, Luis Barra, Hong-Lin Su, Joel A Posener, Khanh H Bui, Michael C Quirk, Timothy M Piser, Sanjay J Mathew and Sanjeev Pathak

Neuropsychopharmacology 2017 42: 844-853; advance online publication, September 29, 2016; 10.1038/npp.2016.224

Abstract | Full Text

Histone Lysine Demethylases of JMJD2 or KDM4 Family are Important Epigenetic Regulators in Reward Circuitry in the Etiopathology of Depression

Salil Saurav Pathak, Swati Maitra, Sumana Chakravarty and Arvind Kumar

Neuropsychopharmacology 2017 42: 854-863; advance online publication, October 6, 2016; 10.1038/npp.2016.231

Abstract | Full Text

Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder

Bhaskar Roy, Michael Dunbar, Richard C Shelton and Yogesh Dwivedi

Neuropsychopharmacology 2017 42: 864-875; advance online publication, August 31, 2016; 10.1038/npp.2016.175

Abstract | Full Text

Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression

David G Harper, J Eric Jensen, Caitlin Ravichandran, Roy H Perlis, Maurizio Fava, Perry F Renshaw and Dan V Iosifescu

Neuropsychopharmacology 2017 42: 876-885; advance online publication, September 2, 2016; 10.1038/npp.2016.180

Abstract | Full Text

TrkB Signaling in Dorsal Raphe Nucleus is Essential for Antidepressant Efficacy and Normal Aggression Behavior

Megumi Adachi, Anita E Autry, Melissa Mahgoub, Kanzo Suzuki and Lisa M Monteggia

Neuropsychopharmacology 2017 42: 886-894; advance online publication, September 16, 2016; 10.1038/npp.2016.201

Abstract | Full Text

β-Adrenergic Receptors Regulate the Acquisition and Consolidation Phases of Aversive Memory Formation Through Distinct, Temporally Regulated Signaling Pathways

Hillary C Schiff, Joshua P Johansen, Mian Hou, David E A Bush, Emily K Smith, JoAnna E Klein, Joseph E LeDoux and Robert M Sears

Neuropsychopharmacology 2017 42: 895-903; advance online publication, October 20, 2016; 10.1038/npp.2016.238

Abstract | Full Text

Involvement of Infralimbic Prefrontal Cortex but not Lateral Habenula in Dopamine Attenuation After Chronic Mild Stress

Jared L Moreines, Zoe L Owrutsky and Anthony A Grace

Neuropsychopharmacology 2017 42: 904-913; advance online publication, November 4, 2016; 10.1038/npp.2016.249

Abstract | Full Text

Hippocampal GABAB(1a) Receptors Constrain Generalized Contextual Fear

Joseph F Lynch, Patrick Winiecki, T Lee Gilman, Jordan M Adkins and Aaron M Jasnow

Neuropsychopharmacology 2017 42: 914-924; advance online publication, November 11, 2016; 10.1038/npp.2016.255

Abstract | Full Text

Associations between Electrophysiological Evidence of Reward and Punishment-Based Learning and Psychotic Experiences and Social Anhedonia in At-Risk Groups

Nicole R Karcher, Bruce D Bartholow, Elizabeth A Martin and John G Kerns

Neuropsychopharmacology 2017 42: 925-932; advance online publication, September 15, 2016; 10.1038/npp.2016.192

Abstract | Full Text

Network-Level Dysconnectivity in Drug-Naïve First-Episode Psychosis: Dissociating Transdiagnostic and Diagnosis-Specific Alterations OPEN

Qiyong Gong, Xinyu Hu, William Pettersson-Yeo, Xin Xu, Su Lui, Nicolas Crossley, Min Wu, Hongyan Zhu and Andrea Mechelli

Neuropsychopharmacology 2017 42: 933-940; advance online publication, October 26, 2016; 10.1038/npp.2016.247

Abstract | Full Text

Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study

Euitae Kim, Oliver D Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun-Sang Lee and Jun Soo Kwon

Neuropsychopharmacology 2017 42: 941-950; advance online publication, November 18, 2016; 10.1038/npp.2016.258

Abstract | Full Text

Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans

Limin Hao, Oshrit Ben-David, Suzann M Babb, Anthony H Futerman, Bruce M Cohen and Edgar A Buttner

Neuropsychopharmacology 2017 42: 951-962; advance online publication, October 6, 2016; 10.1038/npp.2016.230

Abstract | Full Text

Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits

Luke E Sebel, Steven M Graves, C Savio Chan and D James Surmeier

Neuropsychopharmacology 2017 42: 963-973; advance online publication, August 31, 2016; 10.1038/npp.2016.173

Abstract | Full Text

Dysregulation of Striatal Dopamine Receptor Binding in Suicide

Megan L Fitzgerald, Suham A Kassir, Mark D Underwood, Mihran J Bakalian, J John Mann and Victoria Arango

Neuropsychopharmacology 2017 42: 974-982; advance online publication, July 12, 2016; 10.1038/npp.2016.124

Abstract | Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: